Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer
Yuandi Wang,Lijuan Xing,Lexiu Deng,Xinsheng Wang,Dandan Xu,Bu Wang,Zhihua Zhang
DOI: https://doi.org/10.2147/IJGM.S401225
IF: 2.145
2023-03-21
International Journal of General Medicine
Abstract:Yuandi Wang, 1, 2, &ast Lijuan Xing, 2, &ast Lexiu Deng, 1, 2 Xinsheng Wang, 2 Dandan Xu, 2 Bu Wang, 2 Zhihua Zhang 2, &ast 1 Graduate School, Hebei North University, Zhangjiakou City, Hebei Province, People's Republic of China; 2 Department of Respiratory and Critical Care Clinical Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhihua Zhang, Department of Respiratory and Critical Care Clinical Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei Province, People's Republic of China, Tel +86 0313 8033598, Email Purpose: The efficacy of immunotherapy for non-small cell lung cancer (NSCLC) is limited owing to cold tumors and drug resistance. Therefore, it is important to identify the molecular mechanisms underlying immune evasion in NSCLC. Spontaneous ferroptosis of neutrophils has been suggested as a key mechanism of immunosuppression in cancer. Insulin-like growth factor binding protein 1 (IGFBP1) plays an important role in immune infiltration in several cancers. However, the role of IGFBP1 in NSCLC is unknown. Therefore, in this study, we aimed to investigate the association of IGFBP1 mRNA expression with infiltration of myeloid-derived suppressor cells and prognosis in NSCLC. Patients and Methods: Retrospective RNA-seq data from 990 patients in the Cancer Genome Atlas (TCGA) database were analyzed in relation to patient clinical characteristics. The Timer2 database was used to assess immune infiltration, and the FerrDb V2 database was used to obtain ferroptosis-related genes. Finally, the results were validated by the proteomic analysis of serum samples collected from six patients with NSCLC and six healthy individuals. Results: IGFBP1 expression was enriched in lung adenocarcinoma samples and positively correlated with the pathological grade of NSCLC. IGFBP1 expression was an independent prognostic factor for the overall survival of patients with NSCLC. In addition, IGFBP1 expression correlated with myeloid-derived suppressor cell infiltration. Notably, Gene Ontology analysis of IGFBP1 -related genes revealed that the major molecular functions of their protein products were related to NADP + 1-oxidoreductase activity. Furthermore, expression levels of multiple ferroptosis suppressor genes positively correlated with IGFBP1 expression. Conclusion: High IGFBP1 expression indicates a poor prognosis in patients with NSCLC, which may be related to tumor immunosuppression caused by neutrophil ferroptosis. Keywords: immune infiltration, immunotherapy, lung adenocarcinoma, lung squamous cell carcinoma, myeloid-derived suppressor cells Primary lung tumors are among the most common causes of fatal cancer in adults. 1 According to the revised 2021 World Health Organization classification of lung tumors, non-small cell lung cancer (NSCLC) accounts for approximately 85% of all diagnosed lung cancers. Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are the most common histological types of lung cancer. 2 NSCLC is resistant to all current standard treatment measures, including surgery, radiotherapy, and systemic chemotherapy, and most patients with NSCLC eventually relapse. 3 Therefore, new radical treatment strategies are urgently needed for NSCLC. Immunotherapy has shown substantial efficacy in the treatment of many tumors. 4 To date, the most remarkable advancement in cancer therapy is the reactivation of T cell immune responses to tumors following the inhibition of the immune checkpoint activity. 5 Immunotherapy has been used with considerable success in melanoma, renal cell carcinoma, and Hodgkin lymphoma. However, only 20% of patients with NSCLC benefit from immunotherapy. 6 In addition, a recent single-cell RNA sequencing analysis showed that in addition to T lymphocytes, natural killer (NK) cells and different functional subtypes of macrophages and neutrophils are important players in the heterogeneous tumor immune microenvironment. 7 Therefore, the mechanism of immunosuppression in NSCLC requires further investigation. Ferroptosis, an iron-dependent mechanism of regulated cell death triggered by the accumulation of products of toxic lipid peroxidation, is a promising therapeutic target in cancer. 8 Although ferroptosis inducers are highly effective in killing tumor cells in vitro, no obvious effect has been obser -Abstract Truncated-
medicine, general & internal